In recent years, several meetings and reviews have been dedicated to the development of new non-, semi-, or minimally invasive prenatal diagnostic procedures, based on the identification and isolation of fetal cells in maternal peripheral blood or transcervical samples. Consequently, it may seem inappropriate that another conference on this topic should be held so soon and the proceedings published in a special issue of Prenatal Diagnosis. However, this field of research is progressing so rapidly and the practical applications of these investigations are potentially so valuable that Charles Rodeck and I have felt it useful to organize another workshop, particularly since our aims are rather different from those proposed in previous meetings. We hope that, as a result of the various lectures and subsequent discussions, it should be possible to establish whether these new prenatal techniques can be applied to large numbers of 'at risk' pregnant women and eventually used for mass screening in the very near future.In order to achieve these goals, three main questions should be discussed in detail; first of all, we should establish which type of fetal nucleated cells is endowed with the property of reaching the maternal circulation or the endocervical canal and clarify how many cells are involved, how frequently such transfers take place, and at what